Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It seems focused on vaccination strategies, so it's unlikely that your medications will be affected.
Research shows that effective clinician communication, including setting communication goals and reducing patient distress, leads to better patient outcomes and satisfaction. Additionally, direct-to-patient letters, although needing improved readability, have increased during the pandemic, suggesting a growing emphasis on patient-centered communication.
12345The research does not provide specific safety data for communication strategies like Clinician communication or Patient letter, but it does highlight the importance of effective communication in addressing vaccine hesitancy and ensuring vaccine safety awareness.
678910This treatment is unique because it focuses on communication strategies, such as empathy, transparency, and tailored communication, to increase COVID-19 and flu vaccination rates, rather than relying solely on medical interventions. It emphasizes the role of healthcare providers as trusted sources of information and the importance of addressing vaccine hesitancy through effective communication.
1112131415Eligibility Criteria
This trial is for adults aged 19 or older who are registered with one of eight specific adult primary care practices. It aims to increase the rate at which these individuals receive vaccinations against COVID-19 and influenza.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Implementation of two tactics: mailing letters to patients and sending monthly emails to clinicians to improve vaccine uptake
Follow-up
Participants are monitored for vaccine uptake rates and effectiveness of the intervention